Durham spin-out company wins major life sciences award
- 4 days ago
- 1 min read
Nevrargenics, a Durham University spin-out company, has received the Bionow Project of the Year Award at the 2025 Bionow Annual Awards.
The award celebrates projects that have made a major step forward in research and innovation across the UK life sciences sector.
Recognition of breakthrough research:
The winning project centres on Ellorarxine™, Nevrargenics’ lead drug programme, which is being developed as a potential new treatment for Motor Neurone Disease and Frontotemporal Dementia.
Judges praised the project as an important advance in the search for better treatments for these devastating conditions.
